Before you begin your Thanksgiving prep, we recap last week's Clinical Trial Diversity Summit, how the "faceless middleman" is raising your healthcare costs, and promising news from USDA. (890 words, ...

Dr. Matthew Pearson litigates patent cases about pharmaceuticals, chemistry and biology, with a particular focus on biologics and antibody technology. In his work as a scientist, he focused on the ...

Barbara Fiacco is a Partner, co-chair of the Intellectual Property Department and co-chair of the Patent, Trade Secrets, and Related Rights Litigation Practice at Foley Hoag LLP. In her practice, ...

Javeed Froozan’s corporate development experience spans over 25 years in early stage, growth, and large biopharma and health tech firms. This includes acquiring companies, products and technologies in ...

Ryan is a nationally recognized patent litigator who represents clients in the pharmaceutical, biotech, consumer products, telecommunications and high-tech sectors in District Courts, the Federal ...

Improving clinical trial diversity is a shared goal with, perhaps, different motivations for different stakeholders, including but not limited to: ensuring safety and efficacy of medical products in ...

Teon Therapeutics is a private biopharma start-up developing a portfolio of small molecules that modulate metabolic signaling pathways in the tumor microenvironment. Teon's lead program is an ...

Thank you for downloading the BIO Membership Brochure! You can access the brochure below, and we will also send you a copy via email to keep for your records and pass along to your colleagues. If you ...

SEngine Precision Medicine Inc. is a precision oncology company revolutionizing cancer diagnostics and therapies by pre-testing drugs on patient-derived organoids grown ex-vivo utilizing patient ...

OncoSynergy is a clinical stage immuno-oncology therapeutics company pioneering a breakthrough approach to significantly improving outcomes for patients suffering from the worst cancers. Our ...

Nanoligent is a preclinical stage drug discovery company based in Barcelona. We are focused on METASTASIS as an unmet clinical need, developing precision medicines that selectively kill metastatic ...

Aruna Bio, Inc. is a privately funded biotechnology company focused on the development of neural exosomes for the treatment of neurodegenerative diseases. The company utilizes it's proprietary neural ...